Planet Labs PBC (PL)
NYSEIndustrialsAerospace & DefenseSnapshot 2026-09-14
$16.20-1.52%
Close 2026-09-14 · 1-day change
NYSEIndustrialsAerospace & DefenseSnapshot 2026-09-14
Research Workspace
Put PL beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Aerospace & Defense is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue growth is accelerating — up about 44% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 37%, softest on returns on capital.
View QualityManagement screens weak on capital allocation, earnings delivery, margins, the balance sheet.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 3% on a typical day and fell roughly 68% in its worst 12-month stretch.
View RiskPL's growth depends on expanding revenue through strategic agreements, especially with government contracts. Recent Q2 results showed a 58% revenue increase, indicating strong growth potential. It trades at 16× price-to-sales versus a peer median of 3×. This premium suggests the market expects continued strong performance. A risk is the 29% probability of missing outlooks, which could pressure the stock. Peer multiples imply a price about 4% above where it trades. Our read remains intact.
Trailing returns as of 2026-09-14. PL is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 13 analysts currently covering PL (as of Sep 2026).
Based on 6 Wall Street analysts offering 12-month price targets for PL in the last 4 months.
Continue this research
Compare PL with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| PL Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across our valuation methods, at three horizons. As of 2026-09-14. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No fair value published
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
This applies to all three horizons. The trailing multiples, peer comparison, and quality and trajectory reads on this page are unaffected. Names move in and out of this state day to day as the methods converge or diverge. Method agreement on this name is low.
Bottom 25% on quality vs scored peers
A price-focused, side-by-side fair-value read versus Aerospace & Defense — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put PL next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Expand revenue through strategic agreements
Government contracts align with revenue growth objectives.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-14. EPS is implied from price ÷ P/E. Not investment advice.
Current $16.20
The last 12 months of price, then the range of analyst 12-month targets from today’s $16.20.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Advances: Expand revenue through strategic agreements
Significant revenue growth supports strategic agreements objective.
Advances: Expand revenue through strategic agreements
Secures significant revenue through strategic agreement.
Advances: Expand revenue through strategic agreements
Q2 results indicate strong revenue growth potential.
Threatens: Expand revenue through strategic agreements
Guidance falling short may hinder revenue expansion efforts.
Advances: Expand revenue through strategic agreements
Record revenue supports growth objective significantly.
Advances: Expand revenue through strategic agreements
Record revenue supports growth through strategic agreements.
Advances: Expand revenue through strategic agreements
Rwanda deal aligns with revenue expansion objective.
